Doximity soars as Q4 results top estimates

Doximity

17/05/2024 12:25

** Telehealth company Doximity's  DOCS.N  shares climb 15%
to $27.30 premarket
    ** Company's Q4 revenue rises 6% to $118.1 mln, vs est
$116.4 mln - LSEG
    ** Doximity reports better-than-expected Q4 adj EPS of 25
cents vs est 20 cents
    ** "As seen in the past several prints, DOCS continues to 
perform on profitability despite a slightly slower growth 
outlook relative to the Street" - Evercore ISI
    ** Brokerage raises PT on company's shares to $29 from $28
    ** 5 of 19 brokerages rate the stock "buy" or higher, 13
"hold" and 1 "sell" or lower; median PT $30
    ** As of last close, stock down 15.3% YTD

 (Reporting by Nikhil Sharma in Bengaluru)
 ((nikhil.sharma@thomsonreuters.com))